2026 Simcyp Workshops
Advance your PBPK and model-informed drug development expertise with Simcyp workshops. Learn from experts through…
CertaraJune 11, 2026
The Case for Simulating Pregnancy
Pregnant women are routinely excluded from drug trials, leaving clinicians without dosing guidance. Discover how…
CertaraJune 9, 2026
Oxford Academic, Neuro-Oncology Pediatrics – BRAF pub: Growth recovery in patients with BRAF-altered pediatric low-grade glioma following treatment with tovorafenib
This publication reports a pooled retrospective analysis evaluating growth patterns in children with B-Raf proto-oncogene…
Dorottya Gui-BodnarMay 28, 2026
How to Leverage PBPK Modeling and Simulation in Drug Research and Development
Learn how PBPK modeling and simulation in drug research and development reduces clinical burden, supports…
CertaraMay 12, 2026
PBPK Modeling in Pregnancy: Improving Drug Dosing Without Clinical Trials
The FDA is shifting toward approving drugs based on a single pivotal trial supported by…
CertaraMay 12, 2026
The one-trial era: what the FDA’s shift signals for the future of drug development
The FDA is shifting toward approving drugs based on a single pivotal trial supported by…
CertaraMay 6, 2026
